Brokerages predict that Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) will report sales of $44.63 million for the current fiscal quarter, according to Zacks. Five analysts have made estimates for Arrowhead Pharmaceuticals’ earnings. The highest sales estimate is $55.00 million and the lowest is $35.00 million. Arrowhead Pharmaceuticals posted sales of $650,000.00 in the same quarter last year, […]
